Global Minimal Residual Disease (MRD) Testing Market Growth (Status and Outlook) 2026-2032
The global Minimal Residual Disease (MRD) Testing market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
United States market for Minimal Residual Disease (MRD) Testing is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Minimal Residual Disease (MRD) Testing is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Minimal Residual Disease (MRD) Testing is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Minimal Residual Disease (MRD) Testing players cover Sysmex Corporation, Natera, Asuragen, Quest Diagnostics, Mission Bio, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LPI (LP Information)' newest research report, the “Minimal Residual Disease (MRD) Testing Industry Forecast” looks at past sales and reviews total world Minimal Residual Disease (MRD) Testing sales in 2025, providing a comprehensive analysis by region and market sector of projected Minimal Residual Disease (MRD) Testing sales for 2026 through 2032. With Minimal Residual Disease (MRD) Testing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Minimal Residual Disease (MRD) Testing industry.
This Insight Report provides a comprehensive analysis of the global Minimal Residual Disease (MRD) Testing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Minimal Residual Disease (MRD) Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Minimal Residual Disease (MRD) Testing market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Minimal Residual Disease (MRD) Testing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Minimal Residual Disease (MRD) Testing.
This report presents a comprehensive overview, market shares, and growth opportunities of Minimal Residual Disease (MRD) Testing market by product type, application, key players and key regions and countries.
Segmentation by Type:
United States market for Minimal Residual Disease (MRD) Testing is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Minimal Residual Disease (MRD) Testing is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Minimal Residual Disease (MRD) Testing is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Minimal Residual Disease (MRD) Testing players cover Sysmex Corporation, Natera, Asuragen, Quest Diagnostics, Mission Bio, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LPI (LP Information)' newest research report, the “Minimal Residual Disease (MRD) Testing Industry Forecast” looks at past sales and reviews total world Minimal Residual Disease (MRD) Testing sales in 2025, providing a comprehensive analysis by region and market sector of projected Minimal Residual Disease (MRD) Testing sales for 2026 through 2032. With Minimal Residual Disease (MRD) Testing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Minimal Residual Disease (MRD) Testing industry.
This Insight Report provides a comprehensive analysis of the global Minimal Residual Disease (MRD) Testing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Minimal Residual Disease (MRD) Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Minimal Residual Disease (MRD) Testing market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Minimal Residual Disease (MRD) Testing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Minimal Residual Disease (MRD) Testing.
This report presents a comprehensive overview, market shares, and growth opportunities of Minimal Residual Disease (MRD) Testing market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Flow Cytometry
- Polymerase Chain Reaction
- Next-generation Sequencing
- Liquid Biopsies
- Specialty Clinics
- Hospitals
- Research Institutions
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Sysmex Corporation
- Natera
- Asuragen
- Quest Diagnostics
- Mission Bio
- LabCorp
- Guardant Health
- NeoGenomics Laboratories
- ARUP Laboratories
- NeoGenomics , Inc
- Opko Health
- Bio-Rad Laboratories
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Minimal Residual Disease (MRD) Testing Market Size (2021-2032)
2.1.2 Minimal Residual Disease (MRD) Testing Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Minimal Residual Disease (MRD) Testing by Country/Region (2021, 2025 & 2032)
2.2 Minimal Residual Disease (MRD) Testing Segment by Type
2.2.1 Flow Cytometry
2.2.2 Polymerase Chain Reaction
2.2.3 Next-generation Sequencing
2.2.4 Liquid Biopsies
2.2.5 Minimal Residual Disease (MRD) Testing Market Size by Type
2.2.5.1 Minimal Residual Disease (MRD) Testing Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.5.2 Global Minimal Residual Disease (MRD) Testing Market Size Market Share by Type (2021-2026)
2.3 Minimal Residual Disease (MRD) Testing Segment by Application
2.3.1 Specialty Clinics
2.3.2 Hospitals
2.3.3 Research Institutions
2.3.4 Minimal Residual Disease (MRD) Testing Market Size by Application
2.3.4.1 Minimal Residual Disease (MRD) Testing Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.4.2 Global Minimal Residual Disease (MRD) Testing Market Size Market Share by Application (2021-2026)
3 MINIMAL RESIDUAL DISEASE (MRD) TESTING MARKET SIZE BY PLAYER
3.1 Minimal Residual Disease (MRD) Testing Market Size Market Share by Player
3.1.1 Global Minimal Residual Disease (MRD) Testing Revenue by Player (2021-2026)
3.1.2 Global Minimal Residual Disease (MRD) Testing Revenue Market Share by Player (2021-2026)
3.2 Global Minimal Residual Disease (MRD) Testing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 MINIMAL RESIDUAL DISEASE (MRD) TESTING BY REGION
4.1 Minimal Residual Disease (MRD) Testing Market Size by Region (2021-2026)
4.2 Global Minimal Residual Disease (MRD) Testing Annual Revenue by Country/Region (2021-2026)
4.3 Americas Minimal Residual Disease (MRD) Testing Market Size Growth (2021-2026)
4.4 APAC Minimal Residual Disease (MRD) Testing Market Size Growth (2021-2026)
4.5 Europe Minimal Residual Disease (MRD) Testing Market Size Growth (2021-2026)
4.6 Middle East & Africa Minimal Residual Disease (MRD) Testing Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Minimal Residual Disease (MRD) Testing Market Size by Country (2021-2026)
5.2 Americas Minimal Residual Disease (MRD) Testing Market Size by Type (2021-2026)
5.3 Americas Minimal Residual Disease (MRD) Testing Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Minimal Residual Disease (MRD) Testing Market Size by Region (2021-2026)
6.2 APAC Minimal Residual Disease (MRD) Testing Market Size by Type (2021-2026)
6.3 APAC Minimal Residual Disease (MRD) Testing Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Minimal Residual Disease (MRD) Testing Market Size by Country (2021-2026)
7.2 Europe Minimal Residual Disease (MRD) Testing Market Size by Type (2021-2026)
7.3 Europe Minimal Residual Disease (MRD) Testing Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Minimal Residual Disease (MRD) Testing by Region (2021-2026)
8.2 Middle East & Africa Minimal Residual Disease (MRD) Testing Market Size by Type (2021-2026)
8.3 Middle East & Africa Minimal Residual Disease (MRD) Testing Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL MINIMAL RESIDUAL DISEASE (MRD) TESTING MARKET FORECAST
10.1 Global Minimal Residual Disease (MRD) Testing Forecast by Region (2027-2032)
10.1.1 Global Minimal Residual Disease (MRD) Testing Forecast by Region (2027-2032)
10.1.2 Americas Minimal Residual Disease (MRD) Testing Forecast
10.1.3 APAC Minimal Residual Disease (MRD) Testing Forecast
10.1.4 Europe Minimal Residual Disease (MRD) Testing Forecast
10.1.5 Middle East & Africa Minimal Residual Disease (MRD) Testing Forecast
10.2 Americas Minimal Residual Disease (MRD) Testing Forecast by Country (2027-2032)
10.2.1 United States Market Minimal Residual Disease (MRD) Testing Forecast
10.2.2 Canada Market Minimal Residual Disease (MRD) Testing Forecast
10.2.3 Mexico Market Minimal Residual Disease (MRD) Testing Forecast
10.2.4 Brazil Market Minimal Residual Disease (MRD) Testing Forecast
10.3 APAC Minimal Residual Disease (MRD) Testing Forecast by Region (2027-2032)
10.3.1 China Minimal Residual Disease (MRD) Testing Market Forecast
10.3.2 Japan Market Minimal Residual Disease (MRD) Testing Forecast
10.3.3 Korea Market Minimal Residual Disease (MRD) Testing Forecast
10.3.4 Southeast Asia Market Minimal Residual Disease (MRD) Testing Forecast
10.3.5 India Market Minimal Residual Disease (MRD) Testing Forecast
10.3.6 Australia Market Minimal Residual Disease (MRD) Testing Forecast
10.4 Europe Minimal Residual Disease (MRD) Testing Forecast by Country (2027-2032)
10.4.1 Germany Market Minimal Residual Disease (MRD) Testing Forecast
10.4.2 France Market Minimal Residual Disease (MRD) Testing Forecast
10.4.3 UK Market Minimal Residual Disease (MRD) Testing Forecast
10.4.4 Italy Market Minimal Residual Disease (MRD) Testing Forecast
10.4.5 Russia Market Minimal Residual Disease (MRD) Testing Forecast
10.5 Middle East & Africa Minimal Residual Disease (MRD) Testing Forecast by Region (2027-2032)
10.5.1 Egypt Market Minimal Residual Disease (MRD) Testing Forecast
10.5.2 South Africa Market Minimal Residual Disease (MRD) Testing Forecast
10.5.3 Israel Market Minimal Residual Disease (MRD) Testing Forecast
10.5.4 Turkey Market Minimal Residual Disease (MRD) Testing Forecast
10.6 Global Minimal Residual Disease (MRD) Testing Forecast by Type (2027-2032)
10.7 Global Minimal Residual Disease (MRD) Testing Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Minimal Residual Disease (MRD) Testing Forecast
11 KEY PLAYERS ANALYSIS
11.1 Sysmex Corporation
11.1.1 Sysmex Corporation Company Information
11.1.2 Sysmex Corporation Minimal Residual Disease (MRD) Testing Product Offered
11.1.3 Sysmex Corporation Minimal Residual Disease (MRD) Testing Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Sysmex Corporation Main Business Overview
11.1.5 Sysmex Corporation Latest Developments
11.2 Natera
11.2.1 Natera Company Information
11.2.2 Natera Minimal Residual Disease (MRD) Testing Product Offered
11.2.3 Natera Minimal Residual Disease (MRD) Testing Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Natera Main Business Overview
11.2.5 Natera Latest Developments
11.3 Asuragen
11.3.1 Asuragen Company Information
11.3.2 Asuragen Minimal Residual Disease (MRD) Testing Product Offered
11.3.3 Asuragen Minimal Residual Disease (MRD) Testing Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Asuragen Main Business Overview
11.3.5 Asuragen Latest Developments
11.4 Quest Diagnostics
11.4.1 Quest Diagnostics Company Information
11.4.2 Quest Diagnostics Minimal Residual Disease (MRD) Testing Product Offered
11.4.3 Quest Diagnostics Minimal Residual Disease (MRD) Testing Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Quest Diagnostics Main Business Overview
11.4.5 Quest Diagnostics Latest Developments
11.5 Mission Bio
11.5.1 Mission Bio Company Information
11.5.2 Mission Bio Minimal Residual Disease (MRD) Testing Product Offered
11.5.3 Mission Bio Minimal Residual Disease (MRD) Testing Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Mission Bio Main Business Overview
11.5.5 Mission Bio Latest Developments
11.6 LabCorp
11.6.1 LabCorp Company Information
11.6.2 LabCorp Minimal Residual Disease (MRD) Testing Product Offered
11.6.3 LabCorp Minimal Residual Disease (MRD) Testing Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 LabCorp Main Business Overview
11.6.5 LabCorp Latest Developments
11.7 Guardant Health
11.7.1 Guardant Health Company Information
11.7.2 Guardant Health Minimal Residual Disease (MRD) Testing Product Offered
11.7.3 Guardant Health Minimal Residual Disease (MRD) Testing Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Guardant Health Main Business Overview
11.7.5 Guardant Health Latest Developments
11.8 NeoGenomics Laboratories
11.8.1 NeoGenomics Laboratories Company Information
11.8.2 NeoGenomics Laboratories Minimal Residual Disease (MRD) Testing Product Offered
11.8.3 NeoGenomics Laboratories Minimal Residual Disease (MRD) Testing Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 NeoGenomics Laboratories Main Business Overview
11.8.5 NeoGenomics Laboratories Latest Developments
11.9 ARUP Laboratories
11.9.1 ARUP Laboratories Company Information
11.9.2 ARUP Laboratories Minimal Residual Disease (MRD) Testing Product Offered
11.9.3 ARUP Laboratories Minimal Residual Disease (MRD) Testing Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 ARUP Laboratories Main Business Overview
11.9.5 ARUP Laboratories Latest Developments
11.10 NeoGenomics , Inc
11.10.1 NeoGenomics , Inc Company Information
11.10.2 NeoGenomics , Inc Minimal Residual Disease (MRD) Testing Product Offered
11.10.3 NeoGenomics , Inc Minimal Residual Disease (MRD) Testing Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 NeoGenomics , Inc Main Business Overview
11.10.5 NeoGenomics , Inc Latest Developments
11.11 Opko Health
11.11.1 Opko Health Company Information
11.11.2 Opko Health Minimal Residual Disease (MRD) Testing Product Offered
11.11.3 Opko Health Minimal Residual Disease (MRD) Testing Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Opko Health Main Business Overview
11.11.5 Opko Health Latest Developments
11.12 Bio-Rad Laboratories
11.12.1 Bio-Rad Laboratories Company Information
11.12.2 Bio-Rad Laboratories Minimal Residual Disease (MRD) Testing Product Offered
11.12.3 Bio-Rad Laboratories Minimal Residual Disease (MRD) Testing Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Bio-Rad Laboratories Main Business Overview
11.12.5 Bio-Rad Laboratories Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Minimal Residual Disease (MRD) Testing Market Size (2021-2032)
2.1.2 Minimal Residual Disease (MRD) Testing Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Minimal Residual Disease (MRD) Testing by Country/Region (2021, 2025 & 2032)
2.2 Minimal Residual Disease (MRD) Testing Segment by Type
2.2.1 Flow Cytometry
2.2.2 Polymerase Chain Reaction
2.2.3 Next-generation Sequencing
2.2.4 Liquid Biopsies
2.2.5 Minimal Residual Disease (MRD) Testing Market Size by Type
2.2.5.1 Minimal Residual Disease (MRD) Testing Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.5.2 Global Minimal Residual Disease (MRD) Testing Market Size Market Share by Type (2021-2026)
2.3 Minimal Residual Disease (MRD) Testing Segment by Application
2.3.1 Specialty Clinics
2.3.2 Hospitals
2.3.3 Research Institutions
2.3.4 Minimal Residual Disease (MRD) Testing Market Size by Application
2.3.4.1 Minimal Residual Disease (MRD) Testing Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.4.2 Global Minimal Residual Disease (MRD) Testing Market Size Market Share by Application (2021-2026)
3 MINIMAL RESIDUAL DISEASE (MRD) TESTING MARKET SIZE BY PLAYER
3.1 Minimal Residual Disease (MRD) Testing Market Size Market Share by Player
3.1.1 Global Minimal Residual Disease (MRD) Testing Revenue by Player (2021-2026)
3.1.2 Global Minimal Residual Disease (MRD) Testing Revenue Market Share by Player (2021-2026)
3.2 Global Minimal Residual Disease (MRD) Testing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 MINIMAL RESIDUAL DISEASE (MRD) TESTING BY REGION
4.1 Minimal Residual Disease (MRD) Testing Market Size by Region (2021-2026)
4.2 Global Minimal Residual Disease (MRD) Testing Annual Revenue by Country/Region (2021-2026)
4.3 Americas Minimal Residual Disease (MRD) Testing Market Size Growth (2021-2026)
4.4 APAC Minimal Residual Disease (MRD) Testing Market Size Growth (2021-2026)
4.5 Europe Minimal Residual Disease (MRD) Testing Market Size Growth (2021-2026)
4.6 Middle East & Africa Minimal Residual Disease (MRD) Testing Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Minimal Residual Disease (MRD) Testing Market Size by Country (2021-2026)
5.2 Americas Minimal Residual Disease (MRD) Testing Market Size by Type (2021-2026)
5.3 Americas Minimal Residual Disease (MRD) Testing Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Minimal Residual Disease (MRD) Testing Market Size by Region (2021-2026)
6.2 APAC Minimal Residual Disease (MRD) Testing Market Size by Type (2021-2026)
6.3 APAC Minimal Residual Disease (MRD) Testing Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Minimal Residual Disease (MRD) Testing Market Size by Country (2021-2026)
7.2 Europe Minimal Residual Disease (MRD) Testing Market Size by Type (2021-2026)
7.3 Europe Minimal Residual Disease (MRD) Testing Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Minimal Residual Disease (MRD) Testing by Region (2021-2026)
8.2 Middle East & Africa Minimal Residual Disease (MRD) Testing Market Size by Type (2021-2026)
8.3 Middle East & Africa Minimal Residual Disease (MRD) Testing Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL MINIMAL RESIDUAL DISEASE (MRD) TESTING MARKET FORECAST
10.1 Global Minimal Residual Disease (MRD) Testing Forecast by Region (2027-2032)
10.1.1 Global Minimal Residual Disease (MRD) Testing Forecast by Region (2027-2032)
10.1.2 Americas Minimal Residual Disease (MRD) Testing Forecast
10.1.3 APAC Minimal Residual Disease (MRD) Testing Forecast
10.1.4 Europe Minimal Residual Disease (MRD) Testing Forecast
10.1.5 Middle East & Africa Minimal Residual Disease (MRD) Testing Forecast
10.2 Americas Minimal Residual Disease (MRD) Testing Forecast by Country (2027-2032)
10.2.1 United States Market Minimal Residual Disease (MRD) Testing Forecast
10.2.2 Canada Market Minimal Residual Disease (MRD) Testing Forecast
10.2.3 Mexico Market Minimal Residual Disease (MRD) Testing Forecast
10.2.4 Brazil Market Minimal Residual Disease (MRD) Testing Forecast
10.3 APAC Minimal Residual Disease (MRD) Testing Forecast by Region (2027-2032)
10.3.1 China Minimal Residual Disease (MRD) Testing Market Forecast
10.3.2 Japan Market Minimal Residual Disease (MRD) Testing Forecast
10.3.3 Korea Market Minimal Residual Disease (MRD) Testing Forecast
10.3.4 Southeast Asia Market Minimal Residual Disease (MRD) Testing Forecast
10.3.5 India Market Minimal Residual Disease (MRD) Testing Forecast
10.3.6 Australia Market Minimal Residual Disease (MRD) Testing Forecast
10.4 Europe Minimal Residual Disease (MRD) Testing Forecast by Country (2027-2032)
10.4.1 Germany Market Minimal Residual Disease (MRD) Testing Forecast
10.4.2 France Market Minimal Residual Disease (MRD) Testing Forecast
10.4.3 UK Market Minimal Residual Disease (MRD) Testing Forecast
10.4.4 Italy Market Minimal Residual Disease (MRD) Testing Forecast
10.4.5 Russia Market Minimal Residual Disease (MRD) Testing Forecast
10.5 Middle East & Africa Minimal Residual Disease (MRD) Testing Forecast by Region (2027-2032)
10.5.1 Egypt Market Minimal Residual Disease (MRD) Testing Forecast
10.5.2 South Africa Market Minimal Residual Disease (MRD) Testing Forecast
10.5.3 Israel Market Minimal Residual Disease (MRD) Testing Forecast
10.5.4 Turkey Market Minimal Residual Disease (MRD) Testing Forecast
10.6 Global Minimal Residual Disease (MRD) Testing Forecast by Type (2027-2032)
10.7 Global Minimal Residual Disease (MRD) Testing Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Minimal Residual Disease (MRD) Testing Forecast
11 KEY PLAYERS ANALYSIS
11.1 Sysmex Corporation
11.1.1 Sysmex Corporation Company Information
11.1.2 Sysmex Corporation Minimal Residual Disease (MRD) Testing Product Offered
11.1.3 Sysmex Corporation Minimal Residual Disease (MRD) Testing Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Sysmex Corporation Main Business Overview
11.1.5 Sysmex Corporation Latest Developments
11.2 Natera
11.2.1 Natera Company Information
11.2.2 Natera Minimal Residual Disease (MRD) Testing Product Offered
11.2.3 Natera Minimal Residual Disease (MRD) Testing Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Natera Main Business Overview
11.2.5 Natera Latest Developments
11.3 Asuragen
11.3.1 Asuragen Company Information
11.3.2 Asuragen Minimal Residual Disease (MRD) Testing Product Offered
11.3.3 Asuragen Minimal Residual Disease (MRD) Testing Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Asuragen Main Business Overview
11.3.5 Asuragen Latest Developments
11.4 Quest Diagnostics
11.4.1 Quest Diagnostics Company Information
11.4.2 Quest Diagnostics Minimal Residual Disease (MRD) Testing Product Offered
11.4.3 Quest Diagnostics Minimal Residual Disease (MRD) Testing Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Quest Diagnostics Main Business Overview
11.4.5 Quest Diagnostics Latest Developments
11.5 Mission Bio
11.5.1 Mission Bio Company Information
11.5.2 Mission Bio Minimal Residual Disease (MRD) Testing Product Offered
11.5.3 Mission Bio Minimal Residual Disease (MRD) Testing Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Mission Bio Main Business Overview
11.5.5 Mission Bio Latest Developments
11.6 LabCorp
11.6.1 LabCorp Company Information
11.6.2 LabCorp Minimal Residual Disease (MRD) Testing Product Offered
11.6.3 LabCorp Minimal Residual Disease (MRD) Testing Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 LabCorp Main Business Overview
11.6.5 LabCorp Latest Developments
11.7 Guardant Health
11.7.1 Guardant Health Company Information
11.7.2 Guardant Health Minimal Residual Disease (MRD) Testing Product Offered
11.7.3 Guardant Health Minimal Residual Disease (MRD) Testing Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Guardant Health Main Business Overview
11.7.5 Guardant Health Latest Developments
11.8 NeoGenomics Laboratories
11.8.1 NeoGenomics Laboratories Company Information
11.8.2 NeoGenomics Laboratories Minimal Residual Disease (MRD) Testing Product Offered
11.8.3 NeoGenomics Laboratories Minimal Residual Disease (MRD) Testing Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 NeoGenomics Laboratories Main Business Overview
11.8.5 NeoGenomics Laboratories Latest Developments
11.9 ARUP Laboratories
11.9.1 ARUP Laboratories Company Information
11.9.2 ARUP Laboratories Minimal Residual Disease (MRD) Testing Product Offered
11.9.3 ARUP Laboratories Minimal Residual Disease (MRD) Testing Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 ARUP Laboratories Main Business Overview
11.9.5 ARUP Laboratories Latest Developments
11.10 NeoGenomics , Inc
11.10.1 NeoGenomics , Inc Company Information
11.10.2 NeoGenomics , Inc Minimal Residual Disease (MRD) Testing Product Offered
11.10.3 NeoGenomics , Inc Minimal Residual Disease (MRD) Testing Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 NeoGenomics , Inc Main Business Overview
11.10.5 NeoGenomics , Inc Latest Developments
11.11 Opko Health
11.11.1 Opko Health Company Information
11.11.2 Opko Health Minimal Residual Disease (MRD) Testing Product Offered
11.11.3 Opko Health Minimal Residual Disease (MRD) Testing Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Opko Health Main Business Overview
11.11.5 Opko Health Latest Developments
11.12 Bio-Rad Laboratories
11.12.1 Bio-Rad Laboratories Company Information
11.12.2 Bio-Rad Laboratories Minimal Residual Disease (MRD) Testing Product Offered
11.12.3 Bio-Rad Laboratories Minimal Residual Disease (MRD) Testing Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Bio-Rad Laboratories Main Business Overview
11.12.5 Bio-Rad Laboratories Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Minimal Residual Disease (MRD) Testing Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Minimal Residual Disease (MRD) Testing Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Flow Cytometry
Table 4. Major Players of Polymerase Chain Reaction
Table 5. Major Players of Next-generation Sequencing
Table 6. Major Players of Liquid Biopsies
Table 7. Minimal Residual Disease (MRD) Testing Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 8. Global Minimal Residual Disease (MRD) Testing Market Size by Type (2021-2026) & ($ millions)
Table 9. Global Minimal Residual Disease (MRD) Testing Market Size Market Share by Type (2021-2026)
Table 10. Minimal Residual Disease (MRD) Testing Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 11. Global Minimal Residual Disease (MRD) Testing Market Size by Application (2021-2026) & ($ millions)
Table 12. Global Minimal Residual Disease (MRD) Testing Market Size Market Share by Application (2021-2026)
Table 13. Global Minimal Residual Disease (MRD) Testing Revenue by Player (2021-2026) & ($ millions)
Table 14. Global Minimal Residual Disease (MRD) Testing Revenue Market Share by Player (2021-2026)
Table 15. Minimal Residual Disease (MRD) Testing Key Players Head office and Products Offered
Table 16. Minimal Residual Disease (MRD) Testing Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Minimal Residual Disease (MRD) Testing Market Size by Region (2021-2026) & ($ millions)
Table 20. Global Minimal Residual Disease (MRD) Testing Market Size Market Share by Region (2021-2026)
Table 21. Global Minimal Residual Disease (MRD) Testing Revenue by Country/Region (2021-2026) & ($ millions)
Table 22. Global Minimal Residual Disease (MRD) Testing Revenue Market Share by Country/Region (2021-2026)
Table 23. Americas Minimal Residual Disease (MRD) Testing Market Size by Country (2021-2026) & ($ millions)
Table 24. Americas Minimal Residual Disease (MRD) Testing Market Size Market Share by Country (2021-2026)
Table 25. Americas Minimal Residual Disease (MRD) Testing Market Size by Type (2021-2026) & ($ millions)
Table 26. Americas Minimal Residual Disease (MRD) Testing Market Size Market Share by Type (2021-2026)
Table 27. Americas Minimal Residual Disease (MRD) Testing Market Size by Application (2021-2026) & ($ millions)
Table 28. Americas Minimal Residual Disease (MRD) Testing Market Size Market Share by Application (2021-2026)
Table 29. APAC Minimal Residual Disease (MRD) Testing Market Size by Region (2021-2026) & ($ millions)
Table 30. APAC Minimal Residual Disease (MRD) Testing Market Size Market Share by Region (2021-2026)
Table 31. APAC Minimal Residual Disease (MRD) Testing Market Size by Type (2021-2026) & ($ millions)
Table 32. APAC Minimal Residual Disease (MRD) Testing Market Size by Application (2021-2026) & ($ millions)
Table 33. Europe Minimal Residual Disease (MRD) Testing Market Size by Country (2021-2026) & ($ millions)
Table 34. Europe Minimal Residual Disease (MRD) Testing Market Size Market Share by Country (2021-2026)
Table 35. Europe Minimal Residual Disease (MRD) Testing Market Size by Type (2021-2026) & ($ millions)
Table 36. Europe Minimal Residual Disease (MRD) Testing Market Size by Application (2021-2026) & ($ millions)
Table 37. Middle East & Africa Minimal Residual Disease (MRD) Testing Market Size by Region (2021-2026) & ($ millions)
Table 38. Middle East & Africa Minimal Residual Disease (MRD) Testing Market Size by Type (2021-2026) & ($ millions)
Table 39. Middle East & Africa Minimal Residual Disease (MRD) Testing Market Size by Application (2021-2026) & ($ millions)
Table 40. Key Market Drivers & Growth Opportunities of Minimal Residual Disease (MRD) Testing
Table 41. Key Market Challenges & Risks of Minimal Residual Disease (MRD) Testing
Table 42. Key Industry Trends of Minimal Residual Disease (MRD) Testing
Table 43. Global Minimal Residual Disease (MRD) Testing Market Size Forecast by Region (2027-2032) & ($ millions)
Table 44. Global Minimal Residual Disease (MRD) Testing Market Size Market Share Forecast by Region (2027-2032)
Table 45. Global Minimal Residual Disease (MRD) Testing Market Size Forecast by Type (2027-2032) & ($ millions)
Table 46. Global Minimal Residual Disease (MRD) Testing Market Size Forecast by Application (2027-2032) & ($ millions)
Table 47. Sysmex Corporation Details, Company Type, Minimal Residual Disease (MRD) Testing Area Served and Its Competitors
Table 48. Sysmex Corporation Minimal Residual Disease (MRD) Testing Product Offered
Table 49. Sysmex Corporation Minimal Residual Disease (MRD) Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 50. Sysmex Corporation Main Business
Table 51. Sysmex Corporation Latest Developments
Table 52. Natera Details, Company Type, Minimal Residual Disease (MRD) Testing Area Served and Its Competitors
Table 53. Natera Minimal Residual Disease (MRD) Testing Product Offered
Table 54. Natera Minimal Residual Disease (MRD) Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 55. Natera Main Business
Table 56. Natera Latest Developments
Table 57. Asuragen Details, Company Type, Minimal Residual Disease (MRD) Testing Area Served and Its Competitors
Table 58. Asuragen Minimal Residual Disease (MRD) Testing Product Offered
Table 59. Asuragen Minimal Residual Disease (MRD) Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 60. Asuragen Main Business
Table 61. Asuragen Latest Developments
Table 62. Quest Diagnostics Details, Company Type, Minimal Residual Disease (MRD) Testing Area Served and Its Competitors
Table 63. Quest Diagnostics Minimal Residual Disease (MRD) Testing Product Offered
Table 64. Quest Diagnostics Minimal Residual Disease (MRD) Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 65. Quest Diagnostics Main Business
Table 66. Quest Diagnostics Latest Developments
Table 67. Mission Bio Details, Company Type, Minimal Residual Disease (MRD) Testing Area Served and Its Competitors
Table 68. Mission Bio Minimal Residual Disease (MRD) Testing Product Offered
Table 69. Mission Bio Minimal Residual Disease (MRD) Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 70. Mission Bio Main Business
Table 71. Mission Bio Latest Developments
Table 72. LabCorp Details, Company Type, Minimal Residual Disease (MRD) Testing Area Served and Its Competitors
Table 73. LabCorp Minimal Residual Disease (MRD) Testing Product Offered
Table 74. LabCorp Minimal Residual Disease (MRD) Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 75. LabCorp Main Business
Table 76. LabCorp Latest Developments
Table 77. Guardant Health Details, Company Type, Minimal Residual Disease (MRD) Testing Area Served and Its Competitors
Table 78. Guardant Health Minimal Residual Disease (MRD) Testing Product Offered
Table 79. Guardant Health Minimal Residual Disease (MRD) Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 80. Guardant Health Main Business
Table 81. Guardant Health Latest Developments
Table 82. NeoGenomics Laboratories Details, Company Type, Minimal Residual Disease (MRD) Testing Area Served and Its Competitors
Table 83. NeoGenomics Laboratories Minimal Residual Disease (MRD) Testing Product Offered
Table 84. NeoGenomics Laboratories Minimal Residual Disease (MRD) Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 85. NeoGenomics Laboratories Main Business
Table 86. NeoGenomics Laboratories Latest Developments
Table 87. ARUP Laboratories Details, Company Type, Minimal Residual Disease (MRD) Testing Area Served and Its Competitors
Table 88. ARUP Laboratories Minimal Residual Disease (MRD) Testing Product Offered
Table 89. ARUP Laboratories Minimal Residual Disease (MRD) Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 90. ARUP Laboratories Main Business
Table 91. ARUP Laboratories Latest Developments
Table 92. NeoGenomics , Inc Details, Company Type, Minimal Residual Disease (MRD) Testing Area Served and Its Competitors
Table 93. NeoGenomics , Inc Minimal Residual Disease (MRD) Testing Product Offered
Table 94. NeoGenomics , Inc Minimal Residual Disease (MRD) Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 95. NeoGenomics , Inc Main Business
Table 96. NeoGenomics , Inc Latest Developments
Table 97. Opko Health Details, Company Type, Minimal Residual Disease (MRD) Testing Area Served and Its Competitors
Table 98. Opko Health Minimal Residual Disease (MRD) Testing Product Offered
Table 99. Opko Health Minimal Residual Disease (MRD) Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 100. Opko Health Main Business
Table 101. Opko Health Latest Developments
Table 102. Bio-Rad Laboratories Details, Company Type, Minimal Residual Disease (MRD) Testing Area Served and Its Competitors
Table 103. Bio-Rad Laboratories Minimal Residual Disease (MRD) Testing Product Offered
Table 104. Bio-Rad Laboratories Minimal Residual Disease (MRD) Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 105. Bio-Rad Laboratories Main Business
Table 106. Bio-Rad Laboratories Latest Developments
Table 1. Minimal Residual Disease (MRD) Testing Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Minimal Residual Disease (MRD) Testing Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Flow Cytometry
Table 4. Major Players of Polymerase Chain Reaction
Table 5. Major Players of Next-generation Sequencing
Table 6. Major Players of Liquid Biopsies
Table 7. Minimal Residual Disease (MRD) Testing Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 8. Global Minimal Residual Disease (MRD) Testing Market Size by Type (2021-2026) & ($ millions)
Table 9. Global Minimal Residual Disease (MRD) Testing Market Size Market Share by Type (2021-2026)
Table 10. Minimal Residual Disease (MRD) Testing Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 11. Global Minimal Residual Disease (MRD) Testing Market Size by Application (2021-2026) & ($ millions)
Table 12. Global Minimal Residual Disease (MRD) Testing Market Size Market Share by Application (2021-2026)
Table 13. Global Minimal Residual Disease (MRD) Testing Revenue by Player (2021-2026) & ($ millions)
Table 14. Global Minimal Residual Disease (MRD) Testing Revenue Market Share by Player (2021-2026)
Table 15. Minimal Residual Disease (MRD) Testing Key Players Head office and Products Offered
Table 16. Minimal Residual Disease (MRD) Testing Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Minimal Residual Disease (MRD) Testing Market Size by Region (2021-2026) & ($ millions)
Table 20. Global Minimal Residual Disease (MRD) Testing Market Size Market Share by Region (2021-2026)
Table 21. Global Minimal Residual Disease (MRD) Testing Revenue by Country/Region (2021-2026) & ($ millions)
Table 22. Global Minimal Residual Disease (MRD) Testing Revenue Market Share by Country/Region (2021-2026)
Table 23. Americas Minimal Residual Disease (MRD) Testing Market Size by Country (2021-2026) & ($ millions)
Table 24. Americas Minimal Residual Disease (MRD) Testing Market Size Market Share by Country (2021-2026)
Table 25. Americas Minimal Residual Disease (MRD) Testing Market Size by Type (2021-2026) & ($ millions)
Table 26. Americas Minimal Residual Disease (MRD) Testing Market Size Market Share by Type (2021-2026)
Table 27. Americas Minimal Residual Disease (MRD) Testing Market Size by Application (2021-2026) & ($ millions)
Table 28. Americas Minimal Residual Disease (MRD) Testing Market Size Market Share by Application (2021-2026)
Table 29. APAC Minimal Residual Disease (MRD) Testing Market Size by Region (2021-2026) & ($ millions)
Table 30. APAC Minimal Residual Disease (MRD) Testing Market Size Market Share by Region (2021-2026)
Table 31. APAC Minimal Residual Disease (MRD) Testing Market Size by Type (2021-2026) & ($ millions)
Table 32. APAC Minimal Residual Disease (MRD) Testing Market Size by Application (2021-2026) & ($ millions)
Table 33. Europe Minimal Residual Disease (MRD) Testing Market Size by Country (2021-2026) & ($ millions)
Table 34. Europe Minimal Residual Disease (MRD) Testing Market Size Market Share by Country (2021-2026)
Table 35. Europe Minimal Residual Disease (MRD) Testing Market Size by Type (2021-2026) & ($ millions)
Table 36. Europe Minimal Residual Disease (MRD) Testing Market Size by Application (2021-2026) & ($ millions)
Table 37. Middle East & Africa Minimal Residual Disease (MRD) Testing Market Size by Region (2021-2026) & ($ millions)
Table 38. Middle East & Africa Minimal Residual Disease (MRD) Testing Market Size by Type (2021-2026) & ($ millions)
Table 39. Middle East & Africa Minimal Residual Disease (MRD) Testing Market Size by Application (2021-2026) & ($ millions)
Table 40. Key Market Drivers & Growth Opportunities of Minimal Residual Disease (MRD) Testing
Table 41. Key Market Challenges & Risks of Minimal Residual Disease (MRD) Testing
Table 42. Key Industry Trends of Minimal Residual Disease (MRD) Testing
Table 43. Global Minimal Residual Disease (MRD) Testing Market Size Forecast by Region (2027-2032) & ($ millions)
Table 44. Global Minimal Residual Disease (MRD) Testing Market Size Market Share Forecast by Region (2027-2032)
Table 45. Global Minimal Residual Disease (MRD) Testing Market Size Forecast by Type (2027-2032) & ($ millions)
Table 46. Global Minimal Residual Disease (MRD) Testing Market Size Forecast by Application (2027-2032) & ($ millions)
Table 47. Sysmex Corporation Details, Company Type, Minimal Residual Disease (MRD) Testing Area Served and Its Competitors
Table 48. Sysmex Corporation Minimal Residual Disease (MRD) Testing Product Offered
Table 49. Sysmex Corporation Minimal Residual Disease (MRD) Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 50. Sysmex Corporation Main Business
Table 51. Sysmex Corporation Latest Developments
Table 52. Natera Details, Company Type, Minimal Residual Disease (MRD) Testing Area Served and Its Competitors
Table 53. Natera Minimal Residual Disease (MRD) Testing Product Offered
Table 54. Natera Minimal Residual Disease (MRD) Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 55. Natera Main Business
Table 56. Natera Latest Developments
Table 57. Asuragen Details, Company Type, Minimal Residual Disease (MRD) Testing Area Served and Its Competitors
Table 58. Asuragen Minimal Residual Disease (MRD) Testing Product Offered
Table 59. Asuragen Minimal Residual Disease (MRD) Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 60. Asuragen Main Business
Table 61. Asuragen Latest Developments
Table 62. Quest Diagnostics Details, Company Type, Minimal Residual Disease (MRD) Testing Area Served and Its Competitors
Table 63. Quest Diagnostics Minimal Residual Disease (MRD) Testing Product Offered
Table 64. Quest Diagnostics Minimal Residual Disease (MRD) Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 65. Quest Diagnostics Main Business
Table 66. Quest Diagnostics Latest Developments
Table 67. Mission Bio Details, Company Type, Minimal Residual Disease (MRD) Testing Area Served and Its Competitors
Table 68. Mission Bio Minimal Residual Disease (MRD) Testing Product Offered
Table 69. Mission Bio Minimal Residual Disease (MRD) Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 70. Mission Bio Main Business
Table 71. Mission Bio Latest Developments
Table 72. LabCorp Details, Company Type, Minimal Residual Disease (MRD) Testing Area Served and Its Competitors
Table 73. LabCorp Minimal Residual Disease (MRD) Testing Product Offered
Table 74. LabCorp Minimal Residual Disease (MRD) Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 75. LabCorp Main Business
Table 76. LabCorp Latest Developments
Table 77. Guardant Health Details, Company Type, Minimal Residual Disease (MRD) Testing Area Served and Its Competitors
Table 78. Guardant Health Minimal Residual Disease (MRD) Testing Product Offered
Table 79. Guardant Health Minimal Residual Disease (MRD) Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 80. Guardant Health Main Business
Table 81. Guardant Health Latest Developments
Table 82. NeoGenomics Laboratories Details, Company Type, Minimal Residual Disease (MRD) Testing Area Served and Its Competitors
Table 83. NeoGenomics Laboratories Minimal Residual Disease (MRD) Testing Product Offered
Table 84. NeoGenomics Laboratories Minimal Residual Disease (MRD) Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 85. NeoGenomics Laboratories Main Business
Table 86. NeoGenomics Laboratories Latest Developments
Table 87. ARUP Laboratories Details, Company Type, Minimal Residual Disease (MRD) Testing Area Served and Its Competitors
Table 88. ARUP Laboratories Minimal Residual Disease (MRD) Testing Product Offered
Table 89. ARUP Laboratories Minimal Residual Disease (MRD) Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 90. ARUP Laboratories Main Business
Table 91. ARUP Laboratories Latest Developments
Table 92. NeoGenomics , Inc Details, Company Type, Minimal Residual Disease (MRD) Testing Area Served and Its Competitors
Table 93. NeoGenomics , Inc Minimal Residual Disease (MRD) Testing Product Offered
Table 94. NeoGenomics , Inc Minimal Residual Disease (MRD) Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 95. NeoGenomics , Inc Main Business
Table 96. NeoGenomics , Inc Latest Developments
Table 97. Opko Health Details, Company Type, Minimal Residual Disease (MRD) Testing Area Served and Its Competitors
Table 98. Opko Health Minimal Residual Disease (MRD) Testing Product Offered
Table 99. Opko Health Minimal Residual Disease (MRD) Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 100. Opko Health Main Business
Table 101. Opko Health Latest Developments
Table 102. Bio-Rad Laboratories Details, Company Type, Minimal Residual Disease (MRD) Testing Area Served and Its Competitors
Table 103. Bio-Rad Laboratories Minimal Residual Disease (MRD) Testing Product Offered
Table 104. Bio-Rad Laboratories Minimal Residual Disease (MRD) Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 105. Bio-Rad Laboratories Main Business
Table 106. Bio-Rad Laboratories Latest Developments
LIST OF FIGURES
Figure 1. Minimal Residual Disease (MRD) Testing Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Minimal Residual Disease (MRD) Testing Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Minimal Residual Disease (MRD) Testing Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Minimal Residual Disease (MRD) Testing Sales Market Share by Country/Region (2025)
Figure 8. Minimal Residual Disease (MRD) Testing Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Minimal Residual Disease (MRD) Testing Market Size Market Share by Type in 2025
Figure 10. Minimal Residual Disease (MRD) Testing in Specialty Clinics
Figure 11. Global Minimal Residual Disease (MRD) Testing Market: Specialty Clinics (2021-2026) & ($ millions)
Figure 12. Minimal Residual Disease (MRD) Testing in Hospitals
Figure 13. Global Minimal Residual Disease (MRD) Testing Market: Hospitals (2021-2026) & ($ millions)
Figure 14. Minimal Residual Disease (MRD) Testing in Research Institutions
Figure 15. Global Minimal Residual Disease (MRD) Testing Market: Research Institutions (2021-2026) & ($ millions)
Figure 16. Global Minimal Residual Disease (MRD) Testing Market Size Market Share by Application in 2025
Figure 17. Global Minimal Residual Disease (MRD) Testing Revenue Market Share by Player in 2025
Figure 18. Global Minimal Residual Disease (MRD) Testing Market Size Market Share by Region (2021-2026)
Figure 19. Americas Minimal Residual Disease (MRD) Testing Market Size 2021-2026 ($ millions)
Figure 20. APAC Minimal Residual Disease (MRD) Testing Market Size 2021-2026 ($ millions)
Figure 21. Europe Minimal Residual Disease (MRD) Testing Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa Minimal Residual Disease (MRD) Testing Market Size 2021-2026 ($ millions)
Figure 23. Americas Minimal Residual Disease (MRD) Testing Value Market Share by Country in 2025
Figure 24. United States Minimal Residual Disease (MRD) Testing Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada Minimal Residual Disease (MRD) Testing Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico Minimal Residual Disease (MRD) Testing Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil Minimal Residual Disease (MRD) Testing Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC Minimal Residual Disease (MRD) Testing Market Size Market Share by Region in 2025
Figure 29. APAC Minimal Residual Disease (MRD) Testing Market Size Market Share by Type (2021-2026)
Figure 30. APAC Minimal Residual Disease (MRD) Testing Market Size Market Share by Application (2021-2026)
Figure 31. China Minimal Residual Disease (MRD) Testing Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan Minimal Residual Disease (MRD) Testing Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea Minimal Residual Disease (MRD) Testing Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia Minimal Residual Disease (MRD) Testing Market Size Growth 2021-2026 ($ millions)
Figure 35. India Minimal Residual Disease (MRD) Testing Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia Minimal Residual Disease (MRD) Testing Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe Minimal Residual Disease (MRD) Testing Market Size Market Share by Country in 2025
Figure 38. Europe Minimal Residual Disease (MRD) Testing Market Size Market Share by Type (2021-2026)
Figure 39. Europe Minimal Residual Disease (MRD) Testing Market Size Market Share by Application (2021-2026)
Figure 40. Germany Minimal Residual Disease (MRD) Testing Market Size Growth 2021-2026 ($ millions)
Figure 41. France Minimal Residual Disease (MRD) Testing Market Size Growth 2021-2026 ($ millions)
Figure 42. UK Minimal Residual Disease (MRD) Testing Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy Minimal Residual Disease (MRD) Testing Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia Minimal Residual Disease (MRD) Testing Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa Minimal Residual Disease (MRD) Testing Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa Minimal Residual Disease (MRD) Testing Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa Minimal Residual Disease (MRD) Testing Market Size Market Share by Application (2021-2026)
Figure 48. Egypt Minimal Residual Disease (MRD) Testing Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa Minimal Residual Disease (MRD) Testing Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel Minimal Residual Disease (MRD) Testing Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey Minimal Residual Disease (MRD) Testing Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries Minimal Residual Disease (MRD) Testing Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas Minimal Residual Disease (MRD) Testing Market Size 2027-2032 ($ millions)
Figure 54. APAC Minimal Residual Disease (MRD) Testing Market Size 2027-2032 ($ millions)
Figure 55. Europe Minimal Residual Disease (MRD) Testing Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa Minimal Residual Disease (MRD) Testing Market Size 2027-2032 ($ millions)
Figure 57. United States Minimal Residual Disease (MRD) Testing Market Size 2027-2032 ($ millions)
Figure 58. Canada Minimal Residual Disease (MRD) Testing Market Size 2027-2032 ($ millions)
Figure 59. Mexico Minimal Residual Disease (MRD) Testing Market Size 2027-2032 ($ millions)
Figure 60. Brazil Minimal Residual Disease (MRD) Testing Market Size 2027-2032 ($ millions)
Figure 61. China Minimal Residual Disease (MRD) Testing Market Size 2027-2032 ($ millions)
Figure 62. Japan Minimal Residual Disease (MRD) Testing Market Size 2027-2032 ($ millions)
Figure 63. Korea Minimal Residual Disease (MRD) Testing Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia Minimal Residual Disease (MRD) Testing Market Size 2027-2032 ($ millions)
Figure 65. India Minimal Residual Disease (MRD) Testing Market Size 2027-2032 ($ millions)
Figure 66. Australia Minimal Residual Disease (MRD) Testing Market Size 2027-2032 ($ millions)
Figure 67. Germany Minimal Residual Disease (MRD) Testing Market Size 2027-2032 ($ millions)
Figure 68. France Minimal Residual Disease (MRD) Testing Market Size 2027-2032 ($ millions)
Figure 69. UK Minimal Residual Disease (MRD) Testing Market Size 2027-2032 ($ millions)
Figure 70. Italy Minimal Residual Disease (MRD) Testing Market Size 2027-2032 ($ millions)
Figure 71. Russia Minimal Residual Disease (MRD) Testing Market Size 2027-2032 ($ millions)
Figure 72. Egypt Minimal Residual Disease (MRD) Testing Market Size 2027-2032 ($ millions)
Figure 73. South Africa Minimal Residual Disease (MRD) Testing Market Size 2027-2032 ($ millions)
Figure 74. Israel Minimal Residual Disease (MRD) Testing Market Size 2027-2032 ($ millions)
Figure 75. Turkey Minimal Residual Disease (MRD) Testing Market Size 2027-2032 ($ millions)
Figure 76. Global Minimal Residual Disease (MRD) Testing Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global Minimal Residual Disease (MRD) Testing Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries Minimal Residual Disease (MRD) Testing Market Size 2027-2032 ($ millions)
Figure 1. Minimal Residual Disease (MRD) Testing Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Minimal Residual Disease (MRD) Testing Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Minimal Residual Disease (MRD) Testing Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Minimal Residual Disease (MRD) Testing Sales Market Share by Country/Region (2025)
Figure 8. Minimal Residual Disease (MRD) Testing Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Minimal Residual Disease (MRD) Testing Market Size Market Share by Type in 2025
Figure 10. Minimal Residual Disease (MRD) Testing in Specialty Clinics
Figure 11. Global Minimal Residual Disease (MRD) Testing Market: Specialty Clinics (2021-2026) & ($ millions)
Figure 12. Minimal Residual Disease (MRD) Testing in Hospitals
Figure 13. Global Minimal Residual Disease (MRD) Testing Market: Hospitals (2021-2026) & ($ millions)
Figure 14. Minimal Residual Disease (MRD) Testing in Research Institutions
Figure 15. Global Minimal Residual Disease (MRD) Testing Market: Research Institutions (2021-2026) & ($ millions)
Figure 16. Global Minimal Residual Disease (MRD) Testing Market Size Market Share by Application in 2025
Figure 17. Global Minimal Residual Disease (MRD) Testing Revenue Market Share by Player in 2025
Figure 18. Global Minimal Residual Disease (MRD) Testing Market Size Market Share by Region (2021-2026)
Figure 19. Americas Minimal Residual Disease (MRD) Testing Market Size 2021-2026 ($ millions)
Figure 20. APAC Minimal Residual Disease (MRD) Testing Market Size 2021-2026 ($ millions)
Figure 21. Europe Minimal Residual Disease (MRD) Testing Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa Minimal Residual Disease (MRD) Testing Market Size 2021-2026 ($ millions)
Figure 23. Americas Minimal Residual Disease (MRD) Testing Value Market Share by Country in 2025
Figure 24. United States Minimal Residual Disease (MRD) Testing Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada Minimal Residual Disease (MRD) Testing Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico Minimal Residual Disease (MRD) Testing Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil Minimal Residual Disease (MRD) Testing Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC Minimal Residual Disease (MRD) Testing Market Size Market Share by Region in 2025
Figure 29. APAC Minimal Residual Disease (MRD) Testing Market Size Market Share by Type (2021-2026)
Figure 30. APAC Minimal Residual Disease (MRD) Testing Market Size Market Share by Application (2021-2026)
Figure 31. China Minimal Residual Disease (MRD) Testing Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan Minimal Residual Disease (MRD) Testing Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea Minimal Residual Disease (MRD) Testing Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia Minimal Residual Disease (MRD) Testing Market Size Growth 2021-2026 ($ millions)
Figure 35. India Minimal Residual Disease (MRD) Testing Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia Minimal Residual Disease (MRD) Testing Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe Minimal Residual Disease (MRD) Testing Market Size Market Share by Country in 2025
Figure 38. Europe Minimal Residual Disease (MRD) Testing Market Size Market Share by Type (2021-2026)
Figure 39. Europe Minimal Residual Disease (MRD) Testing Market Size Market Share by Application (2021-2026)
Figure 40. Germany Minimal Residual Disease (MRD) Testing Market Size Growth 2021-2026 ($ millions)
Figure 41. France Minimal Residual Disease (MRD) Testing Market Size Growth 2021-2026 ($ millions)
Figure 42. UK Minimal Residual Disease (MRD) Testing Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy Minimal Residual Disease (MRD) Testing Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia Minimal Residual Disease (MRD) Testing Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa Minimal Residual Disease (MRD) Testing Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa Minimal Residual Disease (MRD) Testing Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa Minimal Residual Disease (MRD) Testing Market Size Market Share by Application (2021-2026)
Figure 48. Egypt Minimal Residual Disease (MRD) Testing Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa Minimal Residual Disease (MRD) Testing Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel Minimal Residual Disease (MRD) Testing Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey Minimal Residual Disease (MRD) Testing Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries Minimal Residual Disease (MRD) Testing Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas Minimal Residual Disease (MRD) Testing Market Size 2027-2032 ($ millions)
Figure 54. APAC Minimal Residual Disease (MRD) Testing Market Size 2027-2032 ($ millions)
Figure 55. Europe Minimal Residual Disease (MRD) Testing Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa Minimal Residual Disease (MRD) Testing Market Size 2027-2032 ($ millions)
Figure 57. United States Minimal Residual Disease (MRD) Testing Market Size 2027-2032 ($ millions)
Figure 58. Canada Minimal Residual Disease (MRD) Testing Market Size 2027-2032 ($ millions)
Figure 59. Mexico Minimal Residual Disease (MRD) Testing Market Size 2027-2032 ($ millions)
Figure 60. Brazil Minimal Residual Disease (MRD) Testing Market Size 2027-2032 ($ millions)
Figure 61. China Minimal Residual Disease (MRD) Testing Market Size 2027-2032 ($ millions)
Figure 62. Japan Minimal Residual Disease (MRD) Testing Market Size 2027-2032 ($ millions)
Figure 63. Korea Minimal Residual Disease (MRD) Testing Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia Minimal Residual Disease (MRD) Testing Market Size 2027-2032 ($ millions)
Figure 65. India Minimal Residual Disease (MRD) Testing Market Size 2027-2032 ($ millions)
Figure 66. Australia Minimal Residual Disease (MRD) Testing Market Size 2027-2032 ($ millions)
Figure 67. Germany Minimal Residual Disease (MRD) Testing Market Size 2027-2032 ($ millions)
Figure 68. France Minimal Residual Disease (MRD) Testing Market Size 2027-2032 ($ millions)
Figure 69. UK Minimal Residual Disease (MRD) Testing Market Size 2027-2032 ($ millions)
Figure 70. Italy Minimal Residual Disease (MRD) Testing Market Size 2027-2032 ($ millions)
Figure 71. Russia Minimal Residual Disease (MRD) Testing Market Size 2027-2032 ($ millions)
Figure 72. Egypt Minimal Residual Disease (MRD) Testing Market Size 2027-2032 ($ millions)
Figure 73. South Africa Minimal Residual Disease (MRD) Testing Market Size 2027-2032 ($ millions)
Figure 74. Israel Minimal Residual Disease (MRD) Testing Market Size 2027-2032 ($ millions)
Figure 75. Turkey Minimal Residual Disease (MRD) Testing Market Size 2027-2032 ($ millions)
Figure 76. Global Minimal Residual Disease (MRD) Testing Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global Minimal Residual Disease (MRD) Testing Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries Minimal Residual Disease (MRD) Testing Market Size 2027-2032 ($ millions)
